Xeris Biopharma Holdings (XERS) Inventory (2020 - 2026)
Xeris Biopharma Holdings (XERS) recorded Inventory of $80.93 million in Q2 2026, up 20.3% from $67.28 million a year earlier and up 9.0% from the prior quarter.
Xeris Biopharma Holdings (XERS) Inventory (2020 - 2026) Analysis & Trends
At the end of FY2025, Xeris Biopharma Holdings reported Inventory of $68.67 million, up 42.5% from FY2024.
- Annual Inventory has increased for five straight years, with a five-year compound annual growth rate of 52.4% (FY2020 to FY2025).
- Across earlier years, Inventory came in at $48.18 million in FY2024 (+24.0%), $38.84 million in FY2023 (+57.0%), $24.74 million in FY2022 (+36.5%) and $18.12 million in FY2021 (+116.9%).
- The Q2 2026 figure is the highest quarterly Inventory in data going back to Q4 2020.
- On a year-over-year basis, Inventory has increased for 16 consecutive quarters, with growth averaging 35.1% over the last eight quarters.
- Across the past five years, year-over-year growth in Inventory ran from 17.6% in Q2 2024 to 116.9% in Q4 2021.
- Per Business Quant, the preceding three quarters came in at $74.23 million (Q1 2026), $68.67 million (Q4 2025) and $67.46 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 16.79 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 15.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 5.13 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 6.22 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 6.93 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 6.22 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 9.95 Bn |
| 10 | Xeris Biopharma Holdings | 1.86 Bn | 1.43 Bn | 79.59 Mn | 80.93 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.93 Mn |
| Mar 31, 2026 | 74.23 Mn |
| Dec 31, 2025 | 68.67 Mn |
| Sep 30, 2025 | 67.46 Mn |
| Jun 30, 2025 | 67.28 Mn |
| Mar 31, 2025 | 52.69 Mn |
| Dec 31, 2024 | 48.18 Mn |
| Sep 30, 2024 | 45.12 Mn |
| Jun 30, 2024 | 42.98 Mn |
| Mar 31, 2024 | 40.88 Mn |
| Dec 31, 2023 | 38.84 Mn |
| Sep 30, 2023 | 38.14 Mn |
| Jun 30, 2023 | 36.54 Mn |
| Mar 31, 2023 | 29.04 Mn |
| Dec 31, 2022 | 24.74 Mn |
| Sep 30, 2022 | 20.12 Mn |
| Jun 30, 2022 | 17.89 Mn |
| Mar 31, 2022 | 16.87 Mn |
| Dec 31, 2021 | 18.12 Mn |
| Sep 30, 2021 | 14.24 Mn |
Xeris Biopharma Holdings Inventory API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=inventory&ticker=XERS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "inventory", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=inventory&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();